Terrie Curran - President and Chief Executive, Director at Phathom Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and Chief Executive, Director
Issuer Symbol
PHAT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Terrie Curran since 11 Feb 2025

Holdings reported by Terrie Curran for Phathom Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 360,465 $2,374,635 $6.59 21 Jan 2025 Direct
Common Stock 3,840 $25,298 $6.59 21 Jan 2025 By 401(k)
Stock Option (Right to Buy) 342,500 27 Feb 2025 Direct Common Stock

Transactions reported by Terrie Curran for Phathom Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.